To analyze the efficiency of the ALL-@ protocol ( ClinicalTrials.gov NCT@ @ ) in patients with T-cell leukemias , particularly the role of autologous hematopoietic stem cell transplantation ( auto-HSCT ) after non-myeloablative BEAM conditioning , followed by maintenance therapy .